Trio-Tech International (TRT)
AMEXInformation TechnologySemiconductorsSnapshot 2026-09-04
$10.51+1.55%
Close 2026-09-04 · 1-day change
AMEXInformation TechnologySemiconductorsSnapshot 2026-09-04
QuarterlyIQ Insights · TRT
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $11 TRT trades at 1.8× p/s, below its 4.6× p/s peer median, but our blended $5.17 fair value sits well below the price. We hold it with low confidence: its earnings are too depressed to value on P/E (we anchor on sales instead) and the peer anchor overstates how cheap it looks. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcff | 12M | $1.39 | — | — | Hist. CAGR | high |
| graham number | 12M | $2.22 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $8.43 | 34.8 | 0.21 | TTM | high |
| Peer P/FCF | 12M | $1.07 | 47.2 | 0.02 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 114% over what the business is worth with no growth; closing that gap needs roughly 1.9 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $0.35/sh owner earnings.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $3.10 |
| 47.2 |
| 0.07 |
| TTM |
| high |
| Peer P/S | 12M | $27.49 | 4.6 | 5.99 | TTM | high |
| residual income | 12M | $2.36 | — | — | TTM | high |
| Own P/E history | 12M | $10.49 | 159.7 | 0.07 | TTM | high |
| Peer P/S | 3Y | $34.87 | 4.6 | 7.59 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $40.85 | 4.6 | 8.89 | Hist. CAGR(prov.) | medium |